MGI Tech Technologies for Genetic Sequencing

Founded in 2016 in Shenzhen, MGI Tech is a global leader in life sciences, specializing in genetic sequencing solutions, laboratory automation, and multi-omics analysis. With a customer network spanning over 110 countries, MGI supports precision medicine, agriculture, and public health. MGI Tech has developed a proprietary technology called DNBSEQ™, based on DNA Nanoballs and microstructured arrays, which ensures high accuracy and competitive costs.

The product range includes systems designed for different throughput levels, such as the DNBSEQ-T20×2, which makes large-scale genome sequencing more accessible, and compact benchtop solutions like the DNBSEQ-G99, ideal for laboratories with specific needs. The offering is complemented by integrated solutions for sample preparation, automation, and bioinformatics, along with advanced multi-omics technologies such as spatial and single-cell sequencing. With a strong commitment to innovation, MGI Tech helps make sequencing and genomic analysis more accessible, reliable, and impactful for both research and clinical applications.

Leasing scientific equipment represents an ideal solution for research institutes and companies seeking to optimize resources without compromising research capacity or result quality.

Choosing the leasing of MGI Tech technologies allows access to state-of-the-art instruments without the burden of high upfront investments, ensuring greater financial flexibility and enabling laboratories to remain competitive in a rapidly evolving sector.

This solution not only optimizes financial management but also offers potential tax advantages through the deductibility of leasing fees.